Bellerophon Therapeutics, Inc. (BLPH) is a publicly traded company in the Unknown sector. Across all available filings, 44 corporate insiders have executed 173 transactions totaling $66.2M, demonstrating a bullish sentiment with $48.5M in net insider flow. The most recent transaction on Oct 13, 2023 involved a sale of 1,076,841 shares valued at $107.7K.
No significant insider buying has been recorded for BLPH in the recent period.
No significant insider selling has been recorded for BLPH in the recent period.
Based on recent SEC filings, insider sentiment for BLPH is bullish with an Insider Alignment Score of 87/100 and a net flow of $48.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Bellerophon Therapeutics, Inc. (BLPH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 44 insiders are actively trading BLPH stock, having executed 173 transactions in the past 90 days. The most active insider is Capital Fund (gp) Llc Puissance (Executive), who has made 1 transactions totaling $15.0M.
Get notified when executives and directors at BLPH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 13, 2023 | Science Opportunities Fund VI Puissance Life | Executive | Sale | 1,076,841 | $0.10 | $107.7K | |
| Jun 7, 2023 | Management Lp Puissance Capital | Executive | Sale | 134,421 | $0.83 | $111.6K | |
| Jun 7, 2023 | Amin Naseem | Executive | Award | 47,578 | $N/A | $0 | |
| May 18, 2023 | Management Lp Puissance Capital | Executive | Sale | 560,000 | $9.46 | $5.3M | Large |
| May 18, 2023 | Kim Bobae | Executive | Sale | 9,455 | $10.00 | $94.5K | |
| May 18, 2023 | Kim Bobae | Executive | Option Exercise | 266 | $7.35 | $2.0K | |
| May 18, 2023 | Kim Bobae | Executive | Option Exercise | 1,022 | $7.50 | $7.7K | |
| Feb 10, 2023 | Amin Naseem | Executive | Award | 84,000 | $N/A | $0 | |
| Dec 9, 2022 | Laccona Nicholas | Executive | Payment | 5,530 | $0.93 | $5.1K | |
| Dec 9, 2022 | Laccona Nicholas | Executive | Option Exercise | 18,000 | $N/A | $0 | |
| Dec 9, 2022 | Suresh Shah Parag | Executive | Payment | 7,834 | $0.93 | $7.3K | |
| Dec 9, 2022 | Suresh Shah Parag | Executive | Option Exercise | 25,500 | $N/A | $0 | |
| Dec 9, 2022 | Fernandes Peter | Executive | Option Exercise | 32,500 | $N/A | $0 | |
| Dec 9, 2022 | Fernandes Peter | Executive | Payment | 9,985 | $0.93 | $9.3K | |
| Dec 9, 2022 | Dekker Martin | Executive | Payment | 7,834 | $0.93 | $7.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 67 | $57.4M | 67.9% |
Award(A) | 58 | $17.5M | 20.7% |
Sale(S) | 11 | $8.9M | 10.5% |
Payment(F) | 26 | $773.9K | 0.9% |
Exercise(M) | 7 | $10.1K | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Disposition(D) | 3 | $0 | 0.0% |
Insiders at Bellerophon Therapeutics, Inc. are accumulating shares at an accelerated pace. With 44 insiders making 173 transactions totaling $57.4M in purchases versus $8.9M in sales, the net buying activity of $48.5M signals strong executive confidence. Capital Fund (gp) Llc Puissance (Executive) leads the buying activity with $15.0M in transactions across all time.